HALO Stock UPDATES Halozyme Therapeutics (HALO) 9.12 10/21/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Halozyme Therapeutics (HALO) 9.12 $HALO

NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 5:05PM CDT
NewLink Genetics Corporation (NLNK) has signed an exclusive license agreement with Roche for the development of its oncology candidate, NLG919.
MDVN: 96.97 (+1.99), HALO: 9.12 (-0.03), NLNK: 34.50 (+3.06)

Illumina (ILMN) Tops Q3 Earnings, Revenues; Ups Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:40AM CDT
Illumina Inc.(ILMN) reported adjusted earnings of 77 cents per share in the third quarter of 2014, beating the Zacks Consensus Estimate by 37.5%.
MACK: 8.68 (unch), MDVN: 96.97 (+1.99), HALO: 9.12 (-0.03), ILMN: 179.55 (+15.08)

Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:39AM CDT
Vital Therapies, Inc. (VTL) was a big mover last session, as its shares rose almost 8% on the day.
MACK: 8.68 (unch), HALO: 9.12 (-0.03), VTL: 16.85 (+0.61), ILMN: 179.55 (+15.08)

NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 7:51AM CDT
NewLink Genetics Corporation (NLNK) was a big mover last session, as its shares rose over 7% on the day.
MACK: 8.68 (unch), HALO: 9.12 (-0.03), NLNK: 34.50 (+3.06), ILMN: 179.55 (+15.08)

Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 5:35PM CDT
Amicus Therapeutics, Inc. (FOLD) announced additional positive data from a phase III study (Study 011) on migalastat, for treating Fabry disease patients.
HALO: 9.12 (-0.03), EBS: 21.21 (-0.40), SNY: 52.15 (+0.37), FOLD: 5.82 (-0.12)

Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency
M2 - Mon Oct 20, 10:35AM CDT
Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced the launch and first shipments of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], Baxter's subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the United States. The treatment was approved by the U.S. Food and Drug Administration (FDA) in September of this year.
HALO: 9.12 (-0.03), BAX: 68.65 (+0.71)

Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:39AM CDT
Regeneron Pharmaceuticals, Inc. (REGN) was a big mover last session, as its shares rose nearly 9% on the day.
MACK: 8.68 (unch), HALO: 9.12 (-0.03), EXAS: 24.22 (+0.36), REGN: 381.01 (+14.88)

Emergent BioSolutions (EBS) Jumps: Stock Moves Up 5.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 7:51AM CDT
Emergent BioSolutions, Inc. (EBS) was a big mover last session, as its shares rose nearly 6% on the day.
MACK: 8.68 (unch), HALO: 9.12 (-0.03), EBS: 21.21 (-0.40), EXAS: 24.22 (+0.36)

Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant
PR Newswire - Mon Oct 20, 7:30AM CDT
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved new contract manufacturing facilities used in the production of Hylenex® recombinant (hyaluronidase human injection). The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the Patheon® facility in Greenville, North Carolina, for production of finished Hylenex product.
HALO: 9.12 (-0.03)

Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 4:00PM CDT
Ultragenyx Pharmaceutical Inc. (RARE) reported interim data from a phase II extension study on sialic acid extended-release tablets.
HALO: 9.12 (-0.03), EBS: 21.21 (-0.40), RARE: 47.20 (+1.28), LGND: 50.65 (+0.41)

Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 8:39AM CDT
Novavax, Inc. (NVAX) was a big mover last session, as its shares rose a little over 10% on the day.
MACK: 8.68 (unch), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), NVAX: 4.99 (-0.02)

What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:57AM CDT
Enzo Biochem stock could bring additional losses for your portfolio
HALO: 9.12 (-0.03), EBS: 21.21 (-0.40), ENZ: 4.89 (+0.01), EPZM: 27.62 (+0.03)

Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 7:51AM CDT
Lexicon Pharmaceuticals, Inc. (LXRX) was a big mover last session, as its shares rose over 16% on the day.
MACK: 8.68 (unch), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), LXRX: 1.35 (+0.03)

MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:46AM CDT
MannKind (MNKD) was a big mover last session, with shares rising nearly 13% on the day.
MDVN: 96.97 (+1.99), HALO: 9.12 (-0.03), LGND: 50.65 (+0.41), MNKD: 5.53 (+0.17)

Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:39AM CDT
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as its shares rose nearly 11% on the day.
MACK: 8.68 (unch), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), PPHM: 1.48 (-0.02)

Synageva BioPharma (GEVA) Shows Strength: Stock Up 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 7:51AM CDT
Synageva BioPharma Corp. (GEVA) was a big mover last session, as its shares rose over 7% on the day.
MACK: 8.68 (unch), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), GEVA: 73.14 (-0.96)

Should Genomic Health (GHDX) Be in Your Portfolio Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 5:52PM CDT
On Oct 15, 2014, Zacks Investment Research upgraded Genomic Health Inc. (GHDX) to a Zacks Rank #1 (Strong Buy).
MDVN: 96.97 (+1.99), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), GHDX: 33.76 (+1.00)

Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:46AM CDT
Sunesis Pharmaceuticals (SNSS) was a big mover last session, with shares rising over 8% on the day.
MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), LGND: 50.65 (+0.41), SNSS: 1.47 (-0.03)

MiMedx Group (MDXG) Worth Watching: Stock Rises 9.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 8:39AM CDT
MiMedx Group, Inc. (MDXG) was a big mover last session, as its shares rose nearly 10% on the day.
MACK: 8.68 (unch), MYGN: 36.68 (+1.68), HALO: 9.12 (-0.03), MDXG: 8.65 (+0.26)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterans Find a Haven in Home Helpers® Franchise

Updated Category News Views 70

Veterans Thriving at Home Helpers® Tossing out a warm welcome to fresh horizons post-military, Home Helpers® Home Care is serving up more than just compassionate care—it’s become a bonafide haven for veterans diving into the world of franchising. This isn’t just an indie pat on the back; according to the latest scoop from Franchise Business Review, Home Helpers®...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 86

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 89

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 70

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 0

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 115

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 107

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 65

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading

Top 5 Most Recently Viewed Articles

Ethan Allen Launches Stylish Design Center in Colorado Springs

Updated Category News Views 229

Introducing the New Ethan Allen Design Center Ethan Allen has proudly opened its latest Design Center in Colorado Springs, situated in the vibrant University Village Shopping Center. This newly constructed space features a beautiful gallery showroom, along with workspaces designed for collaboration between designers and clients. This new center is the fourth for Ethan...

Continue Reading
Understanding Ark Invest's Strategic Moves with AI Leaders

Updated Category News Views 349

Ark Invest's Bold Moves in the AI Sector Cathie Wood, the impactful leader of Ark Invest, continues to make headlines with her investment decisions. Recently, Ark made some noteworthy trades involving Baidu Inc. (NASDAQ: BIDU), Alibaba Group Holding Ltd. (NYSE: BABA), and Brera Holdings PLC (NASDAQ: BREA). These investments spotlight Ark's belief in companies championing...

Continue Reading
Broadcom's Future: Analyst Ratings Fuel Optimism for 2026

Updated Category News Views 287

Broadcom's Impressive Rally and Analysts' Confidence Recently, semiconductor giant Broadcom saw a remarkable rebound, achieving a staggering total return of 51%. This performance stands in sharp contrast to the previous year's underwhelming conclusion. Investors have taken a keen interest in the company, especially as it consistently outpaces the S&P 500’s return, which...

Continue Reading
Novavax's Earnings Preview: What Investors Should Expect

Updated Category News Views 160

Key Insights Before Novavax's Earnings Report Novavax (NASDAQ: NVAX) is set to announce its quarterly earnings soon, and anticipation is building among investors. This overview highlights essential factors for those interested in the upcoming earnings report. Expected Earnings Performance Analysts predict that Novavax will report an earnings per share (EPS) of...

Continue Reading
Bank7 Corp. Reports Impressive Q3 2024 Earnings Results

Updated Category News Views 130

Bank7 Corp. Achieves Record Earnings for Q3 2024 Bank7 Corp. (NASDAQ: BSVN), the parent company of Bank7, has announced outstanding financial results for the third quarter of 2024. In a recent statement, President and CEO Thomas L. Travis remarked, "We are pleased to announce another record quarter of net income and EPS. Our properly matched balance sheet, disciplined...

Continue Reading